A Sept. 8 clinical review turns a complicated testing issue into one household habit: keep the medication, timing and preparation context beside the lab result.
A new Medicare Advantage study points to a hidden health-system problem: a plan that feels simple while you are healthy can become complicated after the diagnosis changes.
FDA added a boxed warning to ferric carboxymaltose injection this week. The broader household lesson is to attach a follow-up question to every treatment plan.
